Jordan J Elm

Summary

Affiliation: Medical University of South Carolina
Country: USA

Publications

  1. pmc Screen failure data in clinical trials: Are screening logs worth it?
    Jordan J Elm
    Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA
    Clin Trials 11:467-472. 2014
  2. pmc Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1
    Jordan J Elm
    Division of Biostatistics and Epidemiology, Medical University of South Carolina, 135 Cannon Street, Suite 303, PO Box 250835, Charleston, SC 29425, USA
    Mov Disord 27:1513-21. 2012
  3. pmc Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial
    Jordan J Elm
    Medical University of South Carolina, Charleston, SC, USA
    J Biopharm Stat 22:758-72. 2012
  4. ncbi request reprint A responsive outcome for Parkinson's disease neuroprotection futility studies
    Jordan J Elm
    Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, SC 29425, USA
    Ann Neurol 57:197-203. 2005
  5. ncbi request reprint Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience
    Jordan J Elm
    Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA
    Mov Disord 22:822-7. 2007
  6. ncbi request reprint Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials
    Paulo Guimaraes
    Dept of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, 135 Cannon St Suite 303, Charleston, SC 29425, USA
    Clin Trials 2:509-18. 2005
  7. doi request reprint How common is brain atrophy in patients with medial temporal lobe epilepsy?
    Leonardo Bonilha
    Division of Neurology, Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Epilepsia 51:1774-9. 2010

Detail Information

Publications7

  1. pmc Screen failure data in clinical trials: Are screening logs worth it?
    Jordan J Elm
    Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA
    Clin Trials 11:467-472. 2014
    ..The rationale for collecting screening data includes scientific, trial management, and ethno-socio-cultural reasons...
  2. pmc Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1
    Jordan J Elm
    Division of Biostatistics and Epidemiology, Medical University of South Carolina, 135 Cannon Street, Suite 303, PO Box 250835, Charleston, SC 29425, USA
    Mov Disord 27:1513-21. 2012
    ....
  3. pmc Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial
    Jordan J Elm
    Medical University of South Carolina, Charleston, SC, USA
    J Biopharm Stat 22:758-72. 2012
    ..The flexibility to add a treatment arm to an ongoing trial may result in cost savings as treatments that become ready for testing can be added to ongoing studies...
  4. ncbi request reprint A responsive outcome for Parkinson's disease neuroprotection futility studies
    Jordan J Elm
    Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, SC 29425, USA
    Ann Neurol 57:197-203. 2005
    ....
  5. ncbi request reprint Self-reported adherence versus pill count in Parkinson's disease: the NET-PD experience
    Jordan J Elm
    Department of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, Charleston, South Carolina, USA
    Mov Disord 22:822-7. 2007
    ..To compare the Morisky medication adherence questionnaire to pill counts as measures of adherence in the NET-PD futility clinical trials...
  6. ncbi request reprint Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials
    Paulo Guimaraes
    Dept of Biostatistics, Bioinformatics and Epidemiology, Medical University of South Carolina, 135 Cannon St Suite 303, Charleston, SC 29425, USA
    Clin Trials 2:509-18. 2005
    ..Models can help better understand behavior of the UPDRS after initiation of symptomatic therapy when scores will improve and eventually start deteriorating again...
  7. doi request reprint How common is brain atrophy in patients with medial temporal lobe epilepsy?
    Leonardo Bonilha
    Division of Neurology, Department of Neurosciences, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Epilepsia 51:1774-9. 2010
    ..This study aimed to evaluate where and how much atrophy is to be expected in an individual patient with MTLE...